131 related articles for article (PubMed ID: 3184265)
1. Pharmacokinetics and efficacy of triclabendazole in goats with induced fascioliasis.
Kinabo LD; Bogan JA
J Vet Pharmacol Ther; 1988 Sep; 11(3):254-9. PubMed ID: 3184265
[TBL] [Abstract][Full Text] [Related]
2. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of triclabendazole against Fasciola hepatica in sheep and goats.
Wolff K; Eckert J; Schneiter G; Lutz H
Vet Parasitol; 1983 Sep; 13(2):145-50. PubMed ID: 6685399
[TBL] [Abstract][Full Text] [Related]
4. Measurement of triclabendazole and its metabolites in liver flukes: method development and full validation.
Mottier L; Moreno L; Alvarez L; Virkel G; Lanusse C
J Pharm Biomed Anal; 2004 Sep; 35(5):991-9. PubMed ID: 15336346
[TBL] [Abstract][Full Text] [Related]
5. Isothermal microcalorimetry to study the activity of triclabendazole and its metabolites on juvenile and adult Fasciola hepatica.
Keiser J; Manneck T; Kirchhofer C; Braissant O
Exp Parasitol; 2013 Mar; 133(3):265-8. PubMed ID: 23206957
[TBL] [Abstract][Full Text] [Related]
6. Triclabendazole treatment in experimental goat fasciolosis: anthelmintic efficacy and influence in antibody response and pathophysiology of the disease.
Martínez-Moreno A; Jiménez V; Martínez-Cruz MS; Martínez-Moreno FJ; Becerra C; Hernández S
Vet Parasitol; 1997 Jan; 68(1-2):57-67. PubMed ID: 9066052
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of triclabendazole in rabbits.
Alvarez-Bujidos ML; Ortiz AI; Negro A; Cubría JC; Ordóñez D
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1993 Nov; 106(3):805-8. PubMed ID: 7905812
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle.
Hutchinson GW; Dawson K; Fitzgibbon CC; Martin PJ
Vet Parasitol; 2009 Jun; 162(3-4):278-84. PubMed ID: 19375232
[TBL] [Abstract][Full Text] [Related]
9. Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica.
Mottier L; Virkel G; Solana H; Alvarez L; Salles J; Lanusse C
Xenobiotica; 2004; 34(11-12):1043-57. PubMed ID: 15801547
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and pharmacokinetics of triclabendazole in buffalo with induced fasciolosis.
Sanyal PK; Gupta SC
Vet Parasitol; 1996 May; 63(1-2):75-82. PubMed ID: 8792582
[TBL] [Abstract][Full Text] [Related]
11. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
Robinson MW; Lawson J; Trudgett A; Hoey EM; Fairweather I
Parasitol Res; 2004 Feb; 92(3):205-10. PubMed ID: 14652740
[TBL] [Abstract][Full Text] [Related]
12. Effect of food on the bioavailability of triclabendazole in patients with fascioliasis.
Lecaillon JB; Godbillon J; Campestrini J; Naquira C; Miranda L; Pacheco R; Mull R; Poltera AA
Br J Clin Pharmacol; 1998 Jun; 45(6):601-4. PubMed ID: 9663817
[TBL] [Abstract][Full Text] [Related]
13. Triclabendazole: new skills to unravel an old(ish) enigma.
Fairweather I
J Helminthol; 2005 Sep; 79(3):227-34. PubMed ID: 16153316
[TBL] [Abstract][Full Text] [Related]
14. Triclabendazole resistance involving Fasciola hepatica in sheep and goats during an outbreak in Almirante Tamandare, Paraná, Brazil.
Oliveira DR; Ferreira DM; Stival CC; Romero F; Cavagnolli F; Kloss A; Araújo FB; Molento MB
Rev Bras Parasitol Vet; 2008 Sep; 17 Suppl 1():149-53. PubMed ID: 20059835
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Fasciola hepatica infection in horses with triclabendazole.
Rubilar L; Cabreira A; Giacaman L
Vet Rec; 1988 Sep; 123(12):320-1. PubMed ID: 3195012
[TBL] [Abstract][Full Text] [Related]
16. Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects.
El-Tantawy WH; Salem HF; Mohammed Safwat NA
Pharm World Sci; 2007 Jun; 29(3):190-8. PubMed ID: 17265093
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of triclabendazole against Fasciola hepatica in the donkey (Equus asinus).
Trawford AF; Tremlett JG
Vet Rec; 1996 Aug; 139(6):142-3. PubMed ID: 8863404
[No Abstract] [Full Text] [Related]
18. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole.
Boray JC; Crowfoot PD; Strong MB; Allison JR; Schellenbaum M; Von Orelli M; Sarasin G
Vet Rec; 1983 Oct; 113(14):315-7. PubMed ID: 6649348
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of triclabendazole, nitroxynil and rafoxanide against immature and mature Fasciola hepatica in naturally infected cattle.
Rapic D; Dzakula N; Sakar D; Richards RJ
Vet Rec; 1988 Jan; 122(3):59-62. PubMed ID: 3354156
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of triclabendazole (Fasinex) against immature and adult Fasciola hepatica in experimentally infected cattle.
Shi FH; Lin BF; Qian CG; Li M; Fang MB; Ma JL; Shen W; Wang SW; Jian XL
Vet Parasitol; 1989 Sep; 33(2):117-24. PubMed ID: 2800300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
